ArticleOPEN ACCESS

Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix (Oncotarget (2019) 10 (4262-4275) DOI: 10.18632/oncotarget.27008)

Oncotarget
ISSN: 19492553
3Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

This article has been corrected: Dr. Ashok Sharma has been named as co-corresponding author on this paper, and has been moved from third place to second-to-last author in the listing.

Cite

CITATION STYLE

APA

Mann, M., Kumar, S., Chauhan, S. S., Bhatla, N., Kumar, S., Bakhshi, S., … Kumar, L. (2019). Correction: PARP-1 inhibitor modulate β-catenin signaling to enhance cisplatin sensitivity in cancer cervix (Oncotarget (2019) 10 (4262-4275) DOI: 10.18632/oncotarget.27008). Oncotarget. Impact Journals LLC.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free